These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12368072)

  • 1. A 'crash' course on psychostimulant withdrawal as a model of depression.
    Barr AM; Markou A; Phillips AG
    Trends Pharmacol Sci; 2002 Oct; 23(10):475-82. PubMed ID: 12368072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychostimulant withdrawal as an inducing condition in animal models of depression.
    Barr AM; Markou A
    Neurosci Biobehav Rev; 2005; 29(4-5):675-706. PubMed ID: 15893821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
    Iijima M; Koike H; Chaki S
    Behav Brain Res; 2013 Jun; 246():24-8. PubMed ID: 23473878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.
    Cryan JF; Hoyer D; Markou A
    Biol Psychiatry; 2003 Jul; 54(1):49-58. PubMed ID: 12842308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural substrates of psychostimulant withdrawal-induced anhedonia.
    D'Souza MS; Markou A
    Curr Top Behav Neurosci; 2010; 3():119-78. PubMed ID: 21161752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of psychostimulant withdrawal on latent inhibition of conditioned active avoidance and prepulse inhibition of the acoustic startle response.
    Murphy CA; Di Iorio L; Feldon J
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):155-64. PubMed ID: 11549217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats.
    Barr AM; Zis AP; Phillips AG
    Psychopharmacology (Berl); 2002 Jan; 159(2):196-202. PubMed ID: 11862349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models and treatments for addiction and depression co-morbidity.
    Paterson NE; Markou A
    Neurotox Res; 2007 Jan; 11(1):1-32. PubMed ID: 17449445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptors are involved in the antidepressant-like effects of capsaicin following amphetamine withdrawal in male mice.
    Amiri S; Alijanpour S; Tirgar F; Haj-Mirzaian A; Amini-Khoei H; Rahimi-Balaei M; Rastegar M; Ghaderi M; Ghazi-Khansari M; Zarrindast MR
    Neuroscience; 2016 Aug; 329():122-33. PubMed ID: 27167081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
    Marszalek-Grabska M; Gibula-Bruzda E; Jenda M; Gawel K; Kotlinska JH
    Brain Res; 2016 Jul; 1642():389-396. PubMed ID: 27085203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice.
    Ru Q; Xiong Q; Zhou M; Chen L; Tian X; Xiao H; Li C; Li Y
    Psychiatry Res; 2019 Jan; 271():476-483. PubMed ID: 30544074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice.
    Wu X; Pang G; Zhang YM; Li G; Xu S; Dong L; Stackman RW; Zhang G
    Neurosci Lett; 2015 Oct; 607():23-28. PubMed ID: 26375926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
    Niwa M; Yan Y; Nabeshima T
    Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fencamfamine withdrawal in rats.
    Planeta CS; DeLucia R; Aizenstein ML
    Gen Pharmacol; 1994 Sep; 25(5):931-4. PubMed ID: 7835639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystonia in Methylphenidate Withdrawal: A Case Report.
    Grau-López L; Daigre C; Mercado N; Casas M; Roncero C
    J Addict Med; 2017; 11(2):154-156. PubMed ID: 27926589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine: behavioral effects of withdrawal and related issues.
    Dews PB; O'Brien CP; Bergman J
    Food Chem Toxicol; 2002 Sep; 40(9):1257-61. PubMed ID: 12204389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation.
    James JE; Rogers PJ
    Psychopharmacology (Berl); 2005 Oct; 182(1):1-8. PubMed ID: 16001109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.